637 related articles for article (PubMed ID: 25555473)
1. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
Brown SB; Hankinson SE
Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
[TBL] [Abstract][Full Text] [Related]
2. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.
Eliassen AH; Hankinson SE
Adv Exp Med Biol; 2008; 630():148-65. PubMed ID: 18637490
[TBL] [Abstract][Full Text] [Related]
3. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
4. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
5. Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.
Trabert B; Coburn SB; Falk RT; Manson JE; Brinton LA; Gass ML; Kuller LH; Rohan TE; Pfeiffer RM; Qi L; Stefanick ML; Wentzensen N; Anderson GL; Xu X
Cancer Causes Control; 2019 Nov; 30(11):1201-1211. PubMed ID: 31542834
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
[TBL] [Abstract][Full Text] [Related]
7. Serial endometrial thickness and risk of non-endometrial hormone-dependent cancers in postmenopausal women in UK Collaborative Trial of Ovarian Cancer Screening.
Burnell M; Gentry-Maharaj A; Glazer C; Karpinskyj C; Ryan A; Apostolidou S; Kalsi J; Parmar M; Campbell S; Jacobs I; Menon U
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):267-275. PubMed ID: 31614036
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.
Dallal CM; Lacey JV; Pfeiffer RM; Bauer DC; Falk RT; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Veenstra TD; Xu X; Brinton LA;
Horm Cancer; 2016 Feb; 7(1):49-64. PubMed ID: 26728471
[TBL] [Abstract][Full Text] [Related]
10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
11. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.
Hankinson SE; Eliassen AH
J Steroid Biochem Mol Biol; 2007; 106(1-5):24-30. PubMed ID: 17719770
[TBL] [Abstract][Full Text] [Related]
12. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
13. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25757865
[TBL] [Abstract][Full Text] [Related]
14. Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women.
Key TJ
Steroids; 2011 Jul; 76(8):812-5. PubMed ID: 21477610
[TBL] [Abstract][Full Text] [Related]
15. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.
Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1296-301. PubMed ID: 15298949
[TBL] [Abstract][Full Text] [Related]
16. [Carcinogenesis theory based on estrogen deficiency].
Suba Z
Orv Hetil; 2009 Jun; 150(25):1155-66. PubMed ID: 19497837
[TBL] [Abstract][Full Text] [Related]
17. Sex hormones and breast cancer risk and prognosis.
Folkerd E; Dowsett M
Breast; 2013 Aug; 22 Suppl 2():S38-43. PubMed ID: 24074790
[TBL] [Abstract][Full Text] [Related]
18. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
Bernstein L
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
[TBL] [Abstract][Full Text] [Related]
19. Risks of breast, endometrial, and ovarian cancers after twin births.
Ji J; Försti A; Sundquist J; Hemminki K
Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100
[TBL] [Abstract][Full Text] [Related]
20. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
